197 related articles for article (PubMed ID: 25687792)
1. Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites.
Juhlin K; Karimi G; Andér M; Camilli S; Dheda M; Har TS; Isahak R; Lee SJ; Vaughan S; Caduff P; Norén GN
Drug Saf; 2015 Apr; 38(4):373-82. PubMed ID: 25687792
[TBL] [Abstract][Full Text] [Related]
2. Identification of Substandard Medicines via Disproportionality Analysis of Individual Case Safety Reports.
Trippe ZA; Brendani B; Meier C; Lewis D
Drug Saf; 2017 Apr; 40(4):293-303. PubMed ID: 28130773
[TBL] [Abstract][Full Text] [Related]
3. Detection of cluster adverse drug events in the spontaneous reporting system of China using a disproportionality filter algorithm.
Wang M; Ye X; Ruan Y; Xu J; Guo X; Dong D; Feng H; He J
J Clin Pharm Ther; 2019 Dec; 44(6):952-957. PubMed ID: 31407823
[TBL] [Abstract][Full Text] [Related]
4. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
5. vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues.
Bergvall T; Norén GN; Lindquist M
Drug Saf; 2014 Jan; 37(1):65-77. PubMed ID: 24343765
[TBL] [Abstract][Full Text] [Related]
6. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.
Star K; Norén GN; Nordin K; Edwards IR
Drug Saf; 2011 May; 34(5):415-28. PubMed ID: 21513364
[TBL] [Abstract][Full Text] [Related]
7. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase
Chandler RE; Juhlin K; Fransson J; Caster O; Edwards IR; Norén GN
Drug Saf; 2017 Jan; 40(1):81-90. PubMed ID: 27638661
[TBL] [Abstract][Full Text] [Related]
8. Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre.
Star K; Sandberg L; Bergvall T; Choonara I; Caduff-Janosa P; Edwards IR
Pharmacoepidemiol Drug Saf; 2019 May; 28(5):680-689. PubMed ID: 30767342
[TBL] [Abstract][Full Text] [Related]
9. Bad medicine. Monitoring programs target substandard drugs.
Grens K
Mod Healthc; 2013 May; 43(20):30-1. PubMed ID: 23947275
[No Abstract] [Full Text] [Related]
10. Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.
Ampadu HH; Hoekman J; de Bruin ML; Pal SN; Olsson S; Sartori D; Leufkens HG; Dodoo AN
Drug Saf; 2016 Apr; 39(4):335-45. PubMed ID: 26754924
[TBL] [Abstract][Full Text] [Related]
11. Outlier removal to uncover patterns in adverse drug reaction surveillance - a simple unmasking strategy.
Juhlin K; Ye X; Star K; Norén GN
Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1119-29. PubMed ID: 23832706
[TBL] [Abstract][Full Text] [Related]
12. Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J
Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318
[TBL] [Abstract][Full Text] [Related]
13. Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBase.
Strandell J; Caster O; Bate A; Norén N; Edwards IR
Drug Saf; 2011 Mar; 34(3):253-66. PubMed ID: 21332249
[TBL] [Abstract][Full Text] [Related]
14. Performance of probabilistic method to detect duplicate individual case safety reports.
Tregunno PM; Fink DB; Fernandez-Fernandez C; Lázaro-Bengoa E; Norén GN
Drug Saf; 2014 Apr; 37(4):249-58. PubMed ID: 24627310
[TBL] [Abstract][Full Text] [Related]
15. [Quality of medicines in least developed countries].
Videau JY
Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015
[TBL] [Abstract][Full Text] [Related]
16. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
[TBL] [Abstract][Full Text] [Related]
18. Substandard drugs: a potential crisis for public health.
Johnston A; Holt DW
Br J Clin Pharmacol; 2014 Aug; 78(2):218-43. PubMed ID: 24286459
[TBL] [Abstract][Full Text] [Related]
19. Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis.
Star K; Iessa N; Almandil NB; Wilton L; Curran S; Edwards IR; Wong IC
J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):440-51. PubMed ID: 23234587
[TBL] [Abstract][Full Text] [Related]
20. Provision of information on regulatory authorities' websites.
Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E
Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
